Mankind setting up Rs. 300-crore unit to manufacture fertility hormone.

Mankind Pharma is gearing up to take on one of Abbott India's top selling synthetic hormone brand Duphaston (dydrogesterone) by setting up a dedicated factory in Udaipur, Rajasthan, capable of end-to-end manufacturing of the drug that is widely used for preventing miscarriage and treating infertility.

Mankind is investing about ₹250-₹300 crore on the Udaipur unit that is expected to begin operations by September-October this year.

ET